A Clinical Study of Curcuvail® in Patients With Non-alcoholic Fatty Liver Disease

Summary

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease. It comprises a wide spectrum of disorders that range from simple steatosis to nonalcoholic steatohepatitis (NASH), advanced fibrosis, related cirrhosis, and even hepatocellular carcinoma (HCC).

Timeline

Start

2021-01-08

Primary completion

2021-11-25

Completion

2021-11-25

Drugs

Indications